Dianthus Therapeutics (NASDAQ:DNTH) executives used a Biotech Summit 2026 discussion to outline upcoming clinical catalysts ...
KUALA LUMPUR, Feb 2 (Bernama) -- The National Education Blueprint (RPN) 2026–2035 is expected to significantly increase student participation in Technical and Vocational Education and Training (TVET), ...
1 Infectious Disease and Vaccine, Johnson and Johnson, Spring House, PA, United States 2 Bacterial Vaccine Discovery & Early Development, Johnson and Johnson, Leiden, Netherlands Urinary tract ...
Introduction: Ischemic stroke initiates a cascade of molecular events including increased neuroinflammation, immune dysregulation, and vascular injury, yet the biological mechanisms of post-stroke ...
— Initial Orders Received and Fulfilled from Multiple Transplant Centers, with YARTEMLEA Now Administered to Both Adult and Pediatric Patients with TA-TMA — SEATTLE--(BUSINESS WIRE)--Omeros ...
— Initial Orders Received and Fulfilled from Multiple Transplant Centers, with YARTEMLEA Now Administered to Both Adult and Pediatric Patients with TA-TMA — YARTEMLEA is the first and only approved ...
Omeros Corporation (NASDAQ: OMER) today announced that the first commercial shipments of YARTEMLEA ® (narsoplimab-wuug) to its distributors were completed last week, with orders from transplant ...
— Initial Orders Received and Fulfilled from Multiple Transplant Centers, with YARTEMLEA Now Administered to Both Adult and Pediatric Patients with TA-TMA — Omeros Corporation (NASDAQ: OMER) today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results